Esperion to Participate in Upcoming 2024 Cantor Global Healthcare Conference
Esperion (NASDAQ: ESPR) has announced its participation in the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024, at 10:55 a.m. ET. The event will be webcasted live and accessible through Esperion's investor and media website section. A replay will be available approximately two hours after the call and archived for about 90 days.
Esperion is a company focused on discovering, developing, and commercializing innovative medicines for patients with or at risk of cardiovascular and cardiometabolic diseases. Their mission is to help patients with high cholesterol reach their health goals by providing next steps in LDL-cholesterol reduction.
Esperion (NASDAQ: ESPR) ha annunciato la sua partecipazione alla Conferenza Sanitaria Globale Cantor 2024 che si terrà giovedì 19 settembre 2024, alle 10:55 ET. L'evento sarà trasmesso in diretta e sarà accessibile tramite la sezione dedicata agli investitori e ai media del sito web di Esperion. Una registrazione sarà disponibile circa due ore dopo la chiamata e sarà archiviata per circa 90 giorni.
Esperion è un'azienda focalizzata sul scoprire, sviluppare e commercializzare medicamenti innovativi per pazienti con o a rischio di malattie cardiovascolari e cardiometaboliche. La loro missione è aiutare i pazienti con ipercolesterolemia a raggiungere i loro obiettivi di salute fornendo prossimi passi nella riduzione del colesterolo LDL.
Esperion (NASDAQ: ESPR) ha anunciado su participación en la Conferencia de Atención Médica Global Cantor 2024 el jueves 19 de septiembre de 2024 a las 10:55 a.m. ET. El evento será transmitido en vivo y accesible a través de la sección de inversores y medios del sitio web de Esperion. Una repetición estará disponible aproximadamente dos horas después de la llamada y se archivará por alrededor de 90 días.
Esperion es una empresa centrada en descubrir, desarrollar y comercializar medicamentos innovadores para pacientes con o en riesgo de enfermedades cardiovasculares y cardiometabólicas. Su misión es ayudar a los pacientes con colesterol alto a alcanzar sus objetivos de salud proporcionando próximos pasos en la reducción del colesterol LDL.
Esperion (NASDAQ: ESPR)은 2024 칸토 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 2024년 9월 19일 목요일 오전 10:55 ET에 진행됩니다. 이 행사는 라이브 웹캐스트로 진행되며, Esperion의 투자자 및 미디어 웹사이트 섹션을 통해 접근할 수 있습니다. 재방송은 전화 통화 두 시간 후에 제공되며, 약 90일간 보관됩니다.
Esperion은 심혈관 및 심대사 질환에 대한 혁신적인 의약품을 발견, 개발 및 상용화하는 데 중점을 둔 회사입니다. 그들의 사명은 고콜레스테롤 환자가 LDL 콜레스테롤 감소에 대한 다음 단계를 제공하여 건강 목표를 달성하는 것을 돕는 것입니다.
Esperion (NASDAQ: ESPR) a annoncé sa participation à la Conférence Mondiale de la Santé Cantor 2024 qui se tiendra le jeudi 19 septembre 2024 à 10h55 ET. L'événement sera diffusé en direct et accessible via la section dédiée aux investisseurs et médias du site Web d'Esperion. Une replay sera disponible environ deux heures après l'appel et archivée pendant environ 90 jours.
Esperion est une entreprise axée sur la découverte, le développement et la commercialisation de médicaments innovants pour les patients atteints ou à risque de maladies cardiovasculaires et cardiométaboliques. Leur mission est d'aider les patients ayant un taux de cholestérol élevé à atteindre leurs objectifs de santé en fournissant les prochaines étapes pour la réduction du cholestérol LDL.
Esperion (NASDAQ: ESPR) hat seine Teilnahme an der 2024 Cantor Global Healthcare Conference bekannt gegeben, die am Donnerstag, dem 19. September 2024, um 10:55 Uhr ET stattfindet. Die Veranstaltung wird live übertragen und ist über den Bereich für Investoren und Medien auf der Website von Esperion zugänglich. Eine Wiederholung wird etwa zwei Stunden nach dem Anruf zur Verfügung stehen und etwa 90 Tage archiviert werden.
Esperion ist ein Unternehmen, das sich auf die Entdeckung, Entwicklung und Vermarktung innovativer Medikamente für Patienten mit oder in Gefahr von herz- und kardiometabolischen Erkrankungen konzentriert. Ihre Mission ist es, Patienten mit hohem Cholesterin zu helfen, ihre Gesundheitsziele durch die Bereitstellung von nächsten Schritten zur LDL-Cholesterinreduktion zu erreichen.
- None.
- None.
ANN ARBOR, Mich., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024, at 10:55 a.m. ET.
The live webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for approximately 90 days.
Esperion Therapeutics
At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases. The status quo is not meeting the health needs of millions of people with high cholesterol – that is why our team of passionate industry leaders is breaking through the barriers that prevent patients from reaching their goals. Providers are moving toward reducing LDL-cholesterol levels as low as possible, as soon as possible; we provide the next steps to help get patients there. Because when it comes to high cholesterol, getting to goal is not optional. It is our life’s work. For more information, visit esperion.com and esperionscience.com and follow us on X at twitter.com/EsperionInc.
Esperion Contact Information:
Investors:
Alina Venezia
investorrelations@esperion.com
(734) 887-3903
Media:
Tiffany Aldrich
corporateteam@esperion.com
(616) 443-8438
FAQ
When is Esperion (ESPR) participating in the 2024 Cantor Global Healthcare Conference?
How can I access Esperion's (ESPR) webcast for the 2024 Cantor Global Healthcare Conference?
What is the main focus of Esperion's (ESPR) business?
What is Esperion's (ESPR) approach to treating high cholesterol?
